Evidence map›Paper›PMID 34655571›Full record

ArticleGastroenterology2022

Post-endoscopy Esophageal Neoplasia in Barrett's Esophagus: Consensus Statements From an International Expert Panel.

Sachin Wani, Rena Yadlapati, Siddharth Singh, Tarek Sawas, David A Katzka, Post-Endoscopy Esophageal Neoplasia Expert Consensus Panel

Open access · greenAbstract readConsensus Statement
In one paragraph

Article in Gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett's Esophagus: Expert Review.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Guideline
  4. Review
  5. Article
  6. Emerging Biomarkers for Managing Barrett's Esophagus.Gastrointestinal endoscopy clinics of North America · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Sachin WaniDivision of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Rena YadlapatiDivision of Gastroenterology and Hepatology, University of California, San Diego, San Diego, California.
Siddharth SinghDivision of Gastroenterology and Hepatology, University of California, San Diego, San Diego, California.
Tarek SawasDivision of Gastroenterology and Hepatology, University of Texas Southwestern Medical Center, Dallas, Texas.
David A KatzkaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Post-Endoscopy Esophageal Neoplasia Expert Consensus Panel
University of California, San Diego · USThe University of Texas Southwestern Medical Center · USUniversity of Colorado Anschutz Medical Campus · USWinnMed · US

Funding

Comparative Risks and Benefits of Pharmacological Therapies for Older Patients with Inflammatory Bowel DiseasesK23DK117058 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SINGH, SIDDHARTH · 2018 to 2022
$971k
Mechanism Guided Therapy for Laryngopharyngeal RefluxK23DK125266 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YADLAPATI, RENA HIREN · 2021 to 2025
$963k
A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT TrialU34DK124174 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI DURKALSKI, VALERIE L, SHAHEEN, NICHOLAS J · 2020 to 2020
$384k
Predicting Short- and Long-term Risk of Serious Infections in Older Patients with Inflammatory Bowel DiseasesR03DK129631 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SINGH, SIDDHARTH · 2021 to 2022
$203k
NIDDK NIH HHS K23 DK117058NIDDK NIH HHS K23 DK125266NIDDK NIH HHS R03 DK129631NIDDK NIH HHS U34 DK124174
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaBarrett EsophagusBiopsyEsophageal NeoplasmsEsophagoscopyHumansMissed DiagnosisQuality of Health CareTime FactorsWatchful Waiting

Identifiers

PMID34655571
PMCPMC8792371
OpenAlexW3206443821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.